Clinical Trials Browser

Phase 2 × Not yet recruiting × HR+/HER2- Advanced Breast Cancer × Clear all

NCT06556862 2025-08-13

Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor

Phase 2 Not yet recruiting

HR+/HER2- Advanced Breast Cancer